A rare presentation of KBG syndrome

Authors

  • Dhanya Soodhana Mohan Department of Pediatric and Adolescent Endocrinology, Indira Gandhi Institute of Child Health, Bangalore, Karnataka, India
  • Vani Hebbal Nagarajappa Department of Pediatric and Adolescent Endocrinology, Indira Gandhi Institute of Child Health, Bangalore, Karnataka, India

DOI:

https://doi.org/10.18203/2349-3291.ijcp20212488

Keywords:

KBG syndrome, Short stature, Macrodontia, ANKRD11 gene

Abstract

KBG syndrome is a rare, genetic disorder characterizedby cognitive impairment, short stature, skeletal (mainly costovertebral) anomalies and a distinct craniofacial appearance. It is usually autosomal dominant in nature with a wide range of expressivity in its clinical features. We describe what appears to be the third case reported from India.The aim of this article is to review familiar clinical features and to highlight the endocrine management of KBG syndrome. We are hereby reporting a case of 17 year 10 months old adolescent who had neurocognitive impairment and a characteristic appearance, which led to the diagnosis of this genetic condition.

References

Herrman J, Pallister PD, Tiddy W, Opitz JM. The KGB syndrome-a syndrome of short stature, characteristic facies, mental retardation, macrodontia and skeletal anomalies. Birth Defects Orig Artic Ser. 19;11:7-18.

Brancati F, Sarkozy A, Dallapiccola B. KBG syndrome. Orphanet J Rare Dis. 2006;1:50.

Low K, Ashraf T, Canham N, Clayton-Smith J, Deshpande C, Donaldson A et al. Clinical and genetic aspects of KBG syndrome. Am J Med Genet A. 2016;170:2835-46.

Ockeloen CW, Willemsen MH, De Munnik S, Van Bon BW, De Leeuw N, Verrips A et al. Further delineation of the KBG syndrome caused by ANKDR11 aberrations. Eur J Hum Genet. 2015;23:1176-85.

Kumar H, Prabhu N, Cameron A. KBG syndrome: review of the literature and findingsof 5 affectedpatients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;108(3):e72-9.

Goldenberg A, Riccardi F, Tessier A, Pfundt R, Busa T, Cacciagli P et al. Clinical and molecular findingsin 39 patients with KBG syndrome caused by deletion or mutation of ANKRD11. Am J Med Genet A. 2016;170:2847-59.

Sirmaci A, Spiliopoulos M, Brancati F, Powell E, Duman D, Abrams A et al. Mutations inANKRD11 cause KBG syndrome, characterized by intellectual disability, skeletal malformations, and macrodontia. Am J Hum Genet. 2011;89:289-94.

Li QY, Yang L, Wu J, Lu W, Zhang MY, Luo FH. A case of KBG syndrome caused by mutation ofANKRD11 gene and literature review. Clin J Evid Based Pediatr. 2018;13:452-8.

Hafiz A, Mufeed A, Ismael M, Alam M. An unusual case of KBG syndrome with unique oral findings. BMJ Case Rep. 2015 Jul 17;2015:bcr-2015-210352.

Srivastava P, Gambhir PS, Phadke SR. KBG syndrome: 16q24.3 microdeletion in an Indian patient. Clin Dysmorphol. 2017 Jul;26(3):161-166

Miyatake S, Murakami A, Okamoto N. A de novo deletion at 16q24.3 involving ANKRD11 in a Japanese patient with KBG syndrome. Am J Med Genet A. 2013;161A(5):1073-7.

Zhang A, Yeung PL, Li CW. Identification of a novel family of ankyrin repeats containing cofactors for p160 nuclear receptors coactivators. J Biol Chem. 2004;279(32):33799-805.

Neilsen PM, Cheney KM, Li CW. Identification of ANKRD11 as a p53 coactivator. J Cell Sci. 2008;121:3541-52.

Ge XY, Ge L, Hu WW, Li XL, Hu YY. Growth hormone therapy for children with KBG syndrome: A case report and review of literature. World J Clin Cases. 2020;8(6):1172-9.

Downloads

Published

2021-06-24

Issue

Section

Case Reports